Repaglinide
- Product NDC
- 33342-248
- 11-digit product format
- 333420248
- Labeler code
- 33342
- Product ID
- 33342-248_7a93246c-9323-40c4-b590-a40dcb133c8c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Macleods Pharmaceuticals Limited
- Application
- ANDA207209
- Marketing category
- ANDA
- Marketing start
- 2023-03-22
- Substance
- REPAGLINIDE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Repaglinide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| REPAGLINIDE | .5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 668Z8C33LU |
| Rxcui | 200256, 200257, 200258 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 33342-248-11 | Repaglinide | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
| 33342-248-44 | Repaglinide | 1000 in 1 BOTTLE | TABLET | 1000 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 33342-248 | REPAGLINIDE TABLET [MACLEODS PHARMACEUTICALS LIMITED] | 1 | Current NDC, 2 package rows | 20230405_7a93246c-9323-40c4-b590-a40dcb133c8c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 33342-248-11 | 33342024811 | 100 TABLET in 1 BOTTLE (33342-248-11) | 100 tablet | 2023-03-22 | No | No | Current |
| 33342-248-44 | 33342024844 | 1000 TABLET in 1 BOTTLE (33342-248-44) | 1000 tablet | 2023-03-22 | No | No | Current |